Home / Tag Archives: FDA Approval

Tag Archives: FDA Approval

Siliq (brodalumab) FDA Approval

Siliq brodalumab

Company: Valeant Pharmaceuticals Approval Status: Approved February 2017 Specific Treatments: plaque psoriasis Therapeutic Areas Dermatology General Information Siliq (brodalumab) is a human interleukin-17 receptor A (IL-17RA) antagonist. Siliq is specifically indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response …

Read More »